scholarly article | Q13442814 |
P50 | author | Ovokeraye Achinike-Oduaran | Q58171679 |
Greg Elmer | Q67249076 | ||
P2093 | author name string | Carrie House | |
Norman H Lee | |||
Cheryl L Mayo | |||
Jenica D Tapocik | |||
Bryan Frank | |||
Troung Luu | |||
Russell Williams | |||
Noah Letwin | |||
P2860 | cites work | DeltaFosB: a sustained molecular switch for addiction | Q24555194 |
Identifying biological themes within lists of genes with EASE | Q24630875 | ||
Cluster analysis and display of genome-wide expression patterns | Q24644463 | ||
Within the fold: assessing differential expression measures and reproducibility in microarray assays. | Q24793654 | ||
Analysis of strain and regional variation in gene expression in mouse brain | Q24805884 | ||
Increased glutamate synaptic transmission in the nucleus raphe magnus neurons from morphine-tolerant rats | Q24806600 | ||
Role for a bidentate ribonuclease in the initiation step of RNA interference | Q27860832 | ||
Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray | Q28202142 | ||
Possible physiological role of H19 RNA | Q28204018 | ||
A MicroRNA feedback circuit in midbrain dopamine neurons | Q28513149 | ||
Involvement of protein kinase Cgamma isoform in morphine-induced reinforcing effects | Q28588196 | ||
A brain-specific microRNA regulates dendritic spine development | Q29614753 | ||
Identifying differentially expressed genes using false discovery rate controlling procedures | Q29615200 | ||
Genome-wide expression profiling of mid-gestation placenta and embryo using a 15,000 mouse developmental cDNA microarray | Q30892639 | ||
Tolerance to repeated microinjection of morphine into the periaqueductal gray is associated with changes in the behavior of off- and on-cells in the rostral ventromedial medulla of rats | Q31883785 | ||
Gene expression profiling in the striatum of inbred mouse strains with distinct opioid-related phenotypes | Q33246682 | ||
A genomic screen for activators of the antioxidant response element | Q33278661 | ||
Transcriptional profiling of C57 and DBA strains of mice in the absence and presence of morphine. | Q33279171 | ||
Gene expression profile of neuronal progenitor cells derived from hESCs: activation of chromosome 11p15.5 and comparison to human dopaminergic neurons. | Q33313877 | ||
The neurobiology of opiate reinforcement | Q33647133 | ||
Associative processes in addiction and reward. The role of amygdala-ventral striatal subsystems. | Q33692830 | ||
Genetic analysis of inherited hypertension in the rat. | Q33807196 | ||
Molecular mechanisms and regulation of opioid receptor signaling | Q33932163 | ||
Cellular and synaptic adaptations mediating opioid dependence. | Q34127771 | ||
Neurobiology of addiction | Q34390258 | ||
Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice. | Q34462175 | ||
DNA arrays and neurobiology--what's new and what's next? | Q34942397 | ||
The imprinted H19 noncoding RNA is a primary microRNA precursor | Q35641214 | ||
Interpretation of knockout experiments: the congenic footprint. | Q35839829 | ||
Insights into the receptor transcription and signaling: implications in opioid tolerance and dependence | Q35908741 | ||
Chromosome Mapping of Gene Loci Affecting Morphine and Amphetamine Responses in BXD Recombinant Inbred Mice | Q36330305 | ||
Morphine effects on striatal transcriptome in mice | Q36672435 | ||
Microarrays: an overview | Q36749123 | ||
Neuroplasticity mediated by altered gene expression | Q36922912 | ||
Autocrine activation of an osteopontin-CD44-Rac pathway enhances invasion and transformation by H-RasV12. | Q38334846 | ||
Effects of spinal versus supraspinal administration of cyclic nucleotide-dependent protein kinase inhibitors on morphine tolerance in mice | Q39458411 | ||
Evidence of endogenous mu opioid receptor regulation by epigenetic control of the promoters | Q40142289 | ||
Identification and functional significance of polymorphisms in the mu-opioid receptor gene (Oprm) promoter of C57BL/6 and DBA/2 mice | Q40286769 | ||
Conditioned place preference and locomotor sensitization after repeated administration of cocaine or methamphetamine in rats treated with epidermal growth factor during the neonatal period. | Q40468315 | ||
The role of the basal ganglia in nociception and pain | Q40506202 | ||
Opioid control of MAP kinase cascade | Q40508531 | ||
Identification of Src transformation fingerprint in human colon cancer | Q40698849 | ||
Transcription of the mouse mu-opioid receptor gene is regulated by two promoters | Q41078375 | ||
Localization to chromosome 10 of a locus influencing morphine analgesia in crosses derived from C57BL/ and DBA/2 strains | Q41680280 | ||
Identification and characterization of a novel promoter of the mouse mu opioid receptor gene (Oprm) that generates eight splice variants | Q42526118 | ||
Molecular networks in Dahl salt-sensitive hypertension based on transcriptome analysis of a panel of consomic rats | Q42652986 | ||
Quantitative trait loci influencing morphine antinociception in four mapping populations. | Q43649309 | ||
CTCF mediates interchromosomal colocalization between Igf2/H19 and Wsb1/Nf1. | Q43651581 | ||
Functional interaction between opioid and cannabinoid receptors in drug self-administration. | Q43662870 | ||
Regional mu opioid receptor regulation of sensory and affective dimensions of pain | Q43673019 | ||
Hippocampal long-term potentiation is reduced by chronic opiate treatment and can be restored by re-exposure to opiates. | Q43907014 | ||
Chronic morphine treatment alters endogenous opioid control of hippocampal mossy fiber synaptic transmission | Q43971279 | ||
Genetic variation in morphine analgesic tolerance: a survey of 11 inbred mouse strains | Q44126663 | ||
Affective analgesia following the administration of morphine into the amygdala of rats | Q44257137 | ||
Transgenic superoxide dismutase mice differ in opioid-induced analgesia. | Q44332710 | ||
Identification of three mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon. | Q44333140 | ||
Involvement of cannabinoid (CB1)-receptors in the development and maintenance of opioid tolerance | Q44334528 | ||
Morphine-induced analgesic tolerance, locomotor sensitization and physical dependence do not require modification of mu opioid receptor, cdk5 and adenylate cyclase activity | Q44337241 | ||
Opioid antagonists in the periaqueductal gray inhibit morphine and beta-endorphin analgesia elicited from the amygdala of rats | Q44344755 | ||
The effects of repeated morphine exposure on mu opioid receptor number and affinity in C57BL/6J and DBA/2J mice | Q44347276 | ||
A mitogen-activated protein kinase pathway is required for mu-opioid receptor desensitization | Q44348585 | ||
Chronic pain and genetic background interact and influence opioid analgesia, tolerance, and physical dependence | Q44352053 | ||
PKC and PKA inhibitors reinstate morphine-induced behaviors in morphine tolerant mice | Q44924194 | ||
Mapping of a quantitative trait locus for morphine withdrawal severity | Q45085247 | ||
Confirmation of a major QTL influencing oral morphine intake in C57 and DBA mice using reciprocal congenic strains | Q45126959 | ||
An essential role for DeltaFosB in the nucleus accumbens in morphine action | Q46896171 | ||
Physiogenomic resources for rat models of heart, lung and blood disorders | Q48103779 | ||
Associating quantitative behavioral traits with gene expression in the brain: searching for diamonds in the hay. | Q48385345 | ||
Prefrontal influences upon the midbrain: a possible route for pain modulation | Q48469071 | ||
Combined application of behavior genetics and microarray analysis to identify regional expression themes and gene-behavior associations. | Q48535271 | ||
Role of cAMP response element-binding protein in the rat locus ceruleus: regulation of neuronal activity and opiate withdrawal behaviors. | Q48566183 | ||
Up-regulation of adenosine transporter-binding sites in striatum and hypothalamus of opiate tolerant mice | Q48655768 | ||
Cross-talk of expression quantitative trait loci within 2 interacting blood pressure quantitative trait loci. | Q51577653 | ||
The antinociceptive effect of morphine is reversed by okadaic acid in morphine-naive but not in morphine-tolerant mice. | Q51770072 | ||
Antagonist treatment in nucleus accumbens or periaqueductal grey affects heroin self-administration. | Q51771735 | ||
Associative and nonassociative tolerance: the effects of dose and interdose interval. | Q52194854 | ||
Quantitative trait loci mapping of three loci controlling morphine preference using inbred mouse strains. | Q52272626 | ||
Morphine analgesia in the formalin test: evidence for forebrain and midbrain sites of action. | Q53928500 | ||
Genotype-dependent sensitivity and tolerance to morphine and heroin: dissociation between opiate-induced running and analgesia in the mouse | Q68816521 | ||
Evidence for the dissociation of morphine analgesia, tolerance and dependence | Q69868594 | ||
A study of oral morphine preference in inbred mouse strains | Q72117570 | ||
Genetic variability in morphine sensitivity and tolerance between different strains of rats | Q73822284 | ||
Genetic variance in nociception and its relationship to the potency of morphine-induced analgesia in thermal and chemical tests | Q74435399 | ||
De-differentiation-derived mesenchymal stem cells demonstrate selective repression in H19 bioregulatory RNA gene expression | Q81154406 | ||
Transcriptional profiling with a blood pressure QTL interval-specific oligonucleotide array | Q81309079 | ||
P433 | issue | 16 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 5295-5307 | |
P577 | publication date | 2009-04-01 | |
P1433 | published in | Journal of Neuroscience | Q1709864 |
P1476 | title | Identification of candidate genes and gene networks specifically associated with analgesic tolerance to morphine | |
P478 | volume | 29 |
Q34900986 | 5-hydroxytryptamine type 3 receptor modulates opioid-induced hyperalgesia and tolerance in mice |
Q34183966 | Analysis of candidate genes for morphine preference quantitative trait locus Mop2 |
Q64973158 | Comparison and Functional Genetic Analysis of Striatal Protein Expression Among Diverse Inbred Mouse Strains. |
Q28650541 | Endogenous cholinergic neurotransmission contributes to behavioral sensitization to morphine |
Q34140370 | Endogenous opiates and behavior: 2009 |
Q30452363 | Expression, covariation, and genetic regulation of miRNA Biogenesis genes in brain supports their role in addiction, psychiatric disorders, and disease |
Q34331991 | Inter-strain differences of serotonergic inhibitory pain control in inbred mice |
Q36723555 | MicroRNAs Are Involved in the Development of Morphine-Induced Analgesic Tolerance and Regulate Functionally Relevant Changes in Serpini1. |
Q27316467 | Molecular mechanisms underlying the enhanced analgesic effect of oxycodone compared to morphine in chemotherapy-induced neuropathic pain |
Q37926644 | Natural and engineered coding variation in antidepressant-sensitive serotonin transporters |
Q36335668 | Neuroplasticity, axonal guidance and micro-RNA genes are associated with morphine self-administration behavior |
Q34033859 | Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids. |
Q42395737 | Qualitative differences between C57BL/6J and DBA/2J mice in morphine potentiation of brain stimulation reward and intravenous self-administration |
Q38051560 | Systems biology approaches to finding novel pain mediators |
Q34036170 | TLX1 and NOTCH coregulate transcription in T cell acute lymphoblastic leukemia cells |
Q36003609 | The multiple PDZ domain protein Mpdz/MUPP1 regulates opioid tolerance and opioid-induced hyperalgesia |
Q34363541 | Whole-genome expression profile in zebrafish embryos after chronic exposure to morphine: identification of new genes associated with neuronal function and mu opioid receptor expression |